Home › Merck Raises 2013 Profit Forecast on Progress in Cost Cuts
 

Keywords :   


Merck Raises 2013 Profit Forecast on Progress in Cost Cuts

2013-11-15 02:03:46| Biotech - Topix.net

Merck KGaA, the German maker of the cancer drug Erbitux, raised its profit forecast for the year as cost reductions are taking effect faster than planned.

Tags: cost progress profit cuts

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.11Hurricane Rafael Update Statement
06.11Summary for Hurricane Rafael (AT3/AL182024)
06.11Warning millions will struggle to pay water bill rises
06.11Atlantic Tropical Weather Outlook
06.11Tropical Storm Rafael Graphics
06.11Tropical Storm Rafael Public Advisory Number 9A
06.11Summary for Tropical Storm Rafael (AT3/AL182024)
06.11Eastern North Pacific Tropical Weather Outlook
More »